BARD1 Life Sciences 주식 주식분석 | 주식가격 | 뉴스 | BD1.AX | AU000000BD12 | A2AL50

날짜	BARD1 Life Sciences 주식 가격
	1.03 AUD
	1.06 AUD

날짜	BARD1 Life Sciences 매출	BARD1 Life Sciences EBIT	BARD1 Life Sciences 이익
2021	510,980 AUD	-6.59 백만 AUD	-11.15 백만 AUD
2020	98,390 AUD	-2.33 백만 AUD	-3.25 백만 AUD
2019	8,730 AUD	-1.77 백만 AUD	-1.72 백만 AUD
2018	7,210 AUD	-1.92 백만 AUD	-1.82 백만 AUD
2017	4,200 AUD	-2.59 백만 AUD	-2.6 백만 AUD
2016	0 AUD	-130,000 AUD	-2.84 백만 AUD
2015	0 AUD	0 AUD	0 AUD
2014	0 AUD	0 AUD	0 AUD
2013	10,000 AUD	-610,000 AUD	-10.52 백만 AUD
2012	300,000 AUD	-590,000 AUD	-10.45 백만 AUD
2011	200,000 AUD	-1.03 백만 AUD	-1.56 백만 AUD
2010	1.46 백만 AUD	480,000 AUD	-1.61 백만 AUD
2009	6.93 백만 AUD	5.78 백만 AUD	3.76 백만 AUD
2008	5.88 백만 AUD	4.85 백만 AUD	3.16 백만 AUD
2007	30,000 AUD	700,000 AUD	-11.09 백만 AUD
2006	190,000 AUD	-3.52 백만 AUD	-10.22 백만 AUD
2005	370,000 AUD	-2.27 백만 AUD	-3.13 백만 AUD
2004	630,000 AUD	-690,000 AUD	-1.13 백만 AUD
2003	1.28 백만 AUD	-580,000 AUD	-1.34 백만 AUD
2002	2.25 백만 AUD	-30,000 AUD	-180,000 AUD

	매출	EBIT	이익
2002	2.25 백만 AUD	-30,000 AUD	-180,000 AUD
2003	1.28 백만 AUD	-580,000 AUD	-1.34 백만 AUD
2004	630,000 AUD	-690,000 AUD	-1.13 백만 AUD
2005	370,000 AUD	-2.27 백만 AUD	-3.13 백만 AUD
2006	190,000 AUD	-3.52 백만 AUD	-10.22 백만 AUD
2007	30,000 AUD	700,000 AUD	-11.09 백만 AUD
2008	5.88 백만 AUD	4.85 백만 AUD	3.16 백만 AUD
2009	6.93 백만 AUD	5.78 백만 AUD	3.76 백만 AUD
2010	1.46 백만 AUD	480,000 AUD	-1.61 백만 AUD
2011	200,000 AUD	-1.03 백만 AUD	-1.56 백만 AUD
2012	300,000 AUD	-590,000 AUD	-10.45 백만 AUD
2013	10,000 AUD	-610,000 AUD	-10.52 백만 AUD
2014	0 AUD	0 AUD	0 AUD
2015	0 AUD	0 AUD	0 AUD
2016	0 AUD	-130,000 AUD	-2.84 백만 AUD
2017	4,200 AUD	-2.59 백만 AUD	-2.6 백만 AUD
2018	7,210 AUD	-1.92 백만 AUD	-1.82 백만 AUD
2019	8,730 AUD	-1.77 백만 AUD	-1.72 백만 AUD
2020	98,390 AUD	-2.33 백만 AUD	-3.25 백만 AUD
2021	510,980 AUD	-6.59 백만 AUD	-11.15 백만 AUD

2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021
2	1	0	0	0	0	5	6	1	0	0	0	0	0	0	0	0	0	0	0
-	-50.00	-	-	-	-	-	20.00	-83.33	-	-	-	-	-	-	-	-	-	-	-
50.00	100.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
1,000	1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	-2	-3	0	4	5	0	-1	0	0	0	0	0	-2	-1	-1	-2	-6
-	-	-	-	-	-	80.00	83.33	-	-	-	-	-	-	-	-	-	-	-	-
0	-1	-1	-3	-10	-11	3	3	-1	-1	-10	-10	0	0	-2	-2	-1	-1	-3	-11
-	-	-	200.00	233.33	10.00	-127.27	-	-133.33	-	900.00	-	-	-	-	-	-50.00	-	200.00	266.67
9.57	12.81	15.63	23.33	34.45	40.81	41.62	67.56	83.24	100.53	113.01	113.01	0	0	248.47	18.97	23.9	41.77	45.45	77.27
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021

1.3	1.16	0.37	2.86	0.13	0.51	2.36	15.76	1.96	1.77	0.74	0.21	0.03	1.73	3.12	0.67	1.45	7.56	7.33	5
0.03	0.02	0.05	0.24	0.06	0.01	0.1	0.01	5.37	0	0	0	0.02	0	0.08	0.03	0	0.06	0.02	0.22
100	60	220	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	47.5
0	0	0.23	0.13	0.17	2.26	0.03	0	0.01	0.02	0.23	0.03	0	0	0	0	0	0.01	0.03	0.38
1.43	1.24	0.87	3.23	0.36	2.78	2.49	15.77	7.34	1.79	0.97	0.24	0.05	1.74	3.2	0.7	1.45	7.63	7.37	5.65
0.14	0.2	0.14	0.5	0.32	0.01	0.01	0.01	0.01	0	0	0	0	0	0.01	0	0	0	0	1.73
0	0	0	0.35	0	0	3.63	4.18	12.25	25.05	15.3	3.97	2.76	0.11	0.08	0.03	0	0	0	0
0.01	0.01	0.01	4.26	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.12
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.03
1.3	1.22	2.5	9.11	11.91	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.45	1.43	2.65	14.22	12.23	0.01	3.64	4.19	12.26	25.05	15.3	3.97	2.76	0.11	0.09	0.03	0	0	0	27.87
2.88	2.67	3.52	17.45	12.59	2.79	6.13	19.96	19.6	26.84	16.27	4.21	2.81	1.85	3.29	0.73	1.45	7.63	7.37	33.52

16.05	17.56	18.99	36.21	39.37	41.35	41.35	50.55	50.55	60.04	60.04	60.04	60.04	61.54	6.62	6.65	9.3	16.98	19.29	51.83
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-13.74	-15.09	-16.22	-19.34	-28.32	-38.88	-35.68	-31.91	-33.52	-35.07	-45.52	-56.04	-59.15	-59.78	-3.75	-6.35	-8.13	-9.79	-12.75	-22.75
0	0	0	0	0	-420	0	0	0	0	550	-1,100	0	0	-41.27	-38.09	-42.72	-56.02	-62.91	-22.83
0	0	0	0	0	0	0	0.38	1.85	1.64	0.03	0.02	0	0	0	0	0	0	0	0
2.31	2.47	2.77	16.87	11.05	2.05	5.67	19.02	18.88	26.61	15.1	2.92	0.89	1.76	2.83	0.26	1.13	7.13	6.48	29.06
340	90	690	500	800	120	450	320	60	100	130	140	90	66.37	368.98	422.95	238.21	427.71	798.86	762.14
10	20	40	60	50	130	20	10	10	20	20	10	30	24.05	20.22	35.73	62.39	35.49	77.08	350.36
0	0	0	0	0	0	0	600	640	120	40	10	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	1	1.16	1.82	0	0.07	0	0	0	0	0
0	0	0	0	710	490	0	0	0	0	0	0	0	0	0	0	0	0	0	346.63
0.35	0.11	0.73	0.56	1.56	0.74	0.47	0.93	0.71	0.24	1.19	1.32	1.94	0.09	0.46	0.46	0.3	0.46	0.88	1.46
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	917.5
0.19	0.07	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.06
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.28	22.04	28.66	23.19	29.82
0.19	0.07	0	0	0	0	0	0	0	0	0	0	0	0	0	0.01	0.02	0.03	0.02	3.01
0.54	0.18	0.73	0.56	1.56	0.74	0.47	0.93	0.71	0.24	1.19	1.32	1.94	0.09	0.46	0.47	0.32	0.49	0.9	4.46
2.85	2.65	3.5	17.43	12.61	2.79	6.14	19.95	19.59	26.85	16.29	4.24	2.83	1.85	3.29	0.73	1.45	7.63	7.37	33.52

2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2015	2016	2017	2018	2019	2020	2021
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	-1,000	-2,000	0	0	0	0	0	0	0	0	0	0	0	0	0	1,000
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	-1	0	-4	-5	-3	0	0	0	-1	0	0	0	0	-2	-1	-1	-2	-5
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-1	0	-1	-5	-1	2	1	5	-12	0	0	0	2	0	0	0	0	0	2
0	0	-1	-4	-1	2	1	5	-12	0	0	0	2	0	0	0	0	0	3
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	1,000	0	-2,000	0	0	0	0	0	0
2	1	1	13	3	1	0	0	0	0	0	0	0	3	0	2	8	2	0
2	1	1	12	3	1	0	9	0	0	0	0	0	2	0	2	7	2	0
0	0	0	-1	0	0	0	9	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-1	0	-5	-2	0	12	-14	-1	-1	-1	0	2	-4	-1	4	-3	-8
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

BARD1 Life Sciences 브루토마진	BARD1 Life Sciences 이익 마진	BARD1 Life Sciences EBIT-마진	BARD1 Life Sciences 이익 마진
2021	87.47 %	-1,290.51 %	-2,182.25 %
2020	87.47 %	-2,370.73 %	-3,306.79 %
2019	87.47 %	-20,305.96 %	-19,670.91 %
2018	87.47 %	-26,624.55 %	-25,205.27 %
2017	87.47 %	-61,721.43 %	-62,004.05 %
2016	87.47 %	0 %	0 %
2015	87.47 %	0 %	0 %
2014	87.47 %	0 %	0 %
2013	87.47 %	-6,100 %	-105,200.01 %
2012	87.47 %	-196.67 %	-3,483.33 %
2011	87.47 %	-515 %	-780 %
2010	87.47 %	32.88 %	-110.27 %
2009	87.47 %	83.41 %	54.26 %
2008	87.47 %	82.48 %	53.74 %
2007	87.47 %	2,333.33 %	-36,966.67 %
2006	47.37 %	-1,852.63 %	-5,378.95 %
2005	89.19 %	-613.51 %	-845.95 %
2004	84.13 %	-109.52 %	-179.37 %
2003	86.72 %	-45.31 %	-104.69 %
2002	84.89 %	-1.33 %	-8 %

	브루토마진	EBIT-마진	이익 마진
2002	84.89 %	-1.33 %	-8 %
2003	86.72 %	-45.31 %	-104.69 %
2004	84.13 %	-109.52 %	-179.37 %
2005	89.19 %	-613.51 %	-845.95 %
2006	47.37 %	-1,852.63 %	-5,378.95 %
2007	87.47 %	2,333.33 %	-36,966.67 %
2008	87.47 %	82.48 %	53.74 %
2009	87.47 %	83.41 %	54.26 %
2010	87.47 %	32.88 %	-110.27 %
2011	87.47 %	-515 %	-780 %
2012	87.47 %	-196.67 %	-3,483.33 %
2013	87.47 %	-6,100 %	-105,200.01 %
2014	87.47 %	0 %	0 %
2015	87.47 %	0 %	0 %
2016	87.47 %	0 %	0 %
2017	87.47 %	-61,721.43 %	-62,004.05 %
2018	87.47 %	-26,624.55 %	-25,205.27 %
2019	87.47 %	-20,305.96 %	-19,670.91 %
2020	87.47 %	-2,370.73 %	-3,306.79 %
2021	87.47 %	-1,290.51 %	-2,182.25 %

날짜	BARD1 Life Sciences 주당 매출	BARD1 Life Sciences EBIT 당 주식	BARD1 Life Sciences 주당 이익
2021	0.01 AUD	-0.09 AUD	-0.14 AUD
2020	0 AUD	-0.05 AUD	-0.07 AUD
2019	0 AUD	-0.04 AUD	-0.04 AUD
2018	0 AUD	-0.08 AUD	-0.08 AUD
2017	0 AUD	-0.14 AUD	-0.14 AUD
2016	0 AUD	-0 AUD	-0.01 AUD
2015	0 AUD	0 AUD	0 AUD
2014	0 AUD	0 AUD	0 AUD
2013	0 AUD	-0.01 AUD	-0.09 AUD
2012	0 AUD	-0.01 AUD	-0.09 AUD
2011	0 AUD	-0.01 AUD	-0.02 AUD
2010	0.02 AUD	0.01 AUD	-0.02 AUD
2009	0.1 AUD	0.09 AUD	0.06 AUD
2008	0.14 AUD	0.12 AUD	0.08 AUD
2007	0 AUD	0.02 AUD	-0.27 AUD
2006	0.01 AUD	-0.1 AUD	-0.3 AUD
2005	0.02 AUD	-0.1 AUD	-0.13 AUD
2004	0.04 AUD	-0.04 AUD	-0.07 AUD
2003	0.1 AUD	-0.05 AUD	-0.1 AUD
2002	0.24 AUD	-0 AUD	-0.02 AUD

	주당 매출	EBIT 당 주식	주당 이익
2002	0.24 AUD	-0 AUD	-0.02 AUD
2003	0.1 AUD	-0.05 AUD	-0.1 AUD
2004	0.04 AUD	-0.04 AUD	-0.07 AUD
2005	0.02 AUD	-0.1 AUD	-0.13 AUD
2006	0.01 AUD	-0.1 AUD	-0.3 AUD
2007	0 AUD	0.02 AUD	-0.27 AUD
2008	0.14 AUD	0.12 AUD	0.08 AUD
2009	0.1 AUD	0.09 AUD	0.06 AUD
2010	0.02 AUD	0.01 AUD	-0.02 AUD
2011	0 AUD	-0.01 AUD	-0.02 AUD
2012	0 AUD	-0.01 AUD	-0.09 AUD
2013	0 AUD	-0.01 AUD	-0.09 AUD
2014	0 AUD	0 AUD	0 AUD
2015	0 AUD	0 AUD	0 AUD
2016	0 AUD	-0 AUD	-0.01 AUD
2017	0 AUD	-0.14 AUD	-0.14 AUD
2018	0 AUD	-0.08 AUD	-0.08 AUD
2019	0 AUD	-0.04 AUD	-0.04 AUD
2020	0 AUD	-0.05 AUD	-0.07 AUD
2021	0.01 AUD	-0.09 AUD	-0.14 AUD

	주식 수량
2002	9.57 백만 Aktien
2003	12.81 백만 Aktien
2004	15.63 백만 Aktien
2005	23.33 백만 Aktien
2006	34.45 백만 Aktien
2007	40.81 백만 Aktien
2008	41.62 백만 Aktien
2009	67.56 백만 Aktien
2010	83.24 백만 Aktien
2011	100.53 백만 Aktien
2012	113.01 백만 Aktien
2013	113.01 백만 Aktien
2014	113.01 백만 Aktien
2015	113.01 백만 Aktien
2016	248.47 백만 Aktien
2017	18.97 백만 Aktien
2018	23.9 백만 Aktien
2019	41.77 백만 Aktien
2020	45.45 백만 Aktien
2021	77.27 백만 Aktien

%-지분	이름	주식	변경
14.50317 %	Merchant Funds Management Pty Ltd	11,610,762	-25,596
5.44572 %	Moggs Creek Proprietary Ltd.	4,359,667	1,659,667
5.09639 %	Irminger-Finger (Irmgard)	4,080,000	-40,000
1.50260 %	Traoj Pty. Ltd.	1,202,933	1,202,933
1.38059 %	Neate (David)	1,105,257	1,105,257
1.28524 %	Walker (Tony Michael)	1,028,918	0
1.24596 %	Rodgers (John Andrew)	997,474	619,048
1.05587 %	Emmanuel (Jeffrey Gerard)	845,294	-2,660,678
0.96990 %	Supergun Pty. Ltd.	776,468	0
0.95765 %	Ajava Holdings Pty. Ltd.	766,667	433,334
0.69559 %	Worldwise Enterprises Pty Ltd	556,865	20,593
0.68943 %	Wagner (Nathan Ryan)	551,937	551,937
0.64954 %	Laws (Barrie Ernest)	520,000	520,000
0.64538 %	Wilks (Lynne Maree)	516,667	129,334
0.63150 %	IFM Pty. Ltd.	505,556	505,556
0.62456 %	Hancock (Russell Kay)	500,000	500,000
0.57626 %	Pelagyia Pty. Ltd.	461,333	461,333
0.50503 %	Johnston (Max)	404,310	93,021
0.40800 %	Powell (Philip)	326,631	40,000
0.18043 %	Cumming (Geoffrey James Ph.D.)	144,447	19,354
0 %	Gunzburg (Peter Lynton)	0	-1,312,740

What values and corporate philosophy does BARD1 Life Sciences represent?

BARD1 Life Sciences Ltd represents values of innovation, excellence, and integrity. With a strong corporate philosophy focused on advancing the field of precision medicine, BARD1 Life Sciences Ltd seeks to improve patient outcomes through the development of diagnostic tests for early cancer detection. The company has a commitment to conducting research that contributes to the understanding of cancer biology and the identification of novel biomarkers. BARD1 Life Sciences Ltd places great importance on collaboration with leading institutions and industry partners to accelerate the translation of scientific discoveries into clinical practice. With a dedicated team, BARD1 Life Sciences Ltd strives to make a positive impact in the fight against cancer.

In which countries and regions is BARD1 Life Sciences primarily present?

BARD1 Life Sciences Ltd is primarily present in Australia.

What significant milestones has the company BARD1 Life Sciences achieved?

BARD1 Life Sciences Ltd has achieved several significant milestones. The company has successfully developed a novel and highly specific cancer diagnostic test, known as BARD1 Ovarian Cancer Test, which has shown promising results in early detection and monitoring of ovarian cancer. BARD1 has also established collaborations with renowned research institutions and pharmaceutical companies to further develop their portfolio of diagnostic and therapeutic products. The company has received recognition and grants for its innovative research and has secured partnerships to expand its global reach. BARD1 Life Sciences Ltd is committed to making impactful contributions to the field of cancer detection and treatment.

What is the history and background of the company BARD1 Life Sciences?

BARD1 Life Sciences Ltd is a biotechnology company based in Australia. Established in 2004, BARD1 focuses on developing and commercializing innovative diagnostics and therapeutics for cancer. The company is engaged in the research and development of novel diagnostic tests that detect specific cancer biomarkers. With a strong emphasis on early cancer detection and personalized medicine, BARD1 aims to improve patient outcomes through its cutting-edge technologies. The company has a dedicated team of scientists and researchers who work tirelessly to advance their product pipeline. BARD1 Life Sciences Ltd is committed to making a significant impact in the field of cancer diagnostics and improving the lives of patients worldwide.

Who are the main competitors of BARD1 Life Sciences in the market?

The main competitors of BARD1 Life Sciences Ltd in the market include other companies operating in the field of life sciences and diagnostics. Some notable competitors include companies like Illumina Inc., Thermo Fisher Scientific Inc., and QIAGEN N.V. These companies, like BARD1 Life Sciences Ltd, are engaged in the development and commercialization of innovative diagnostic tests and technologies. Their competition fosters continuous innovation and drives advancements in the life sciences industry.

In which industries is BARD1 Life Sciences primarily active?

BARD1 Life Sciences Ltd is primarily active in the biotechnology and life sciences industries.

What is the business model of BARD1 Life Sciences?

The business model of BARD1 Life Sciences Ltd is focused on the development and commercialization of cancer diagnostics and therapeutics. Specializing in precision oncology, BARD1 aims to identify and develop innovative biomarkers and companion diagnostics for early detection and personalized treatment of various cancers. By leveraging its proprietary technology and strategic collaborations, BARD1 Life Sciences is committed to improving patient outcomes and providing advancements in the field of cancer management.

BARD1 Life Sciences 2024의 P/E 비율은 얼마입니까?

BARD1 Life Sciences에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

BARD1 Life Sciences 2024의 KUV는 얼마입니까?

BARD1 Life Sciences에 대한 현재 KUV는 계산할 수 없습니다.

BARD1 Life Sciences의 AlleAktien 품질 점수는 얼마인가요?

BARD1 Life Sciences에 대한 AlleAktien 품질 점수는 5/10입니다.

BARD1 Life Sciences 2024의 매출은 얼마인가요?

BARD1 Life Sciences에 대한 현재 매출은 계산할 수 없습니다.

BARD1 Life Sciences 2024의 이익은 얼마인가요?

BARD1 Life Sciences의 현재 이익을 계산할 수 없습니다.

BARD1 Life Sciences은 무엇을 하나요?

The BARD1 Life Sciences Ltd is an Australian biotechnology company specializing in the development of innovative cancer therapies. It focuses on the research and development of diagnostic and therapeutic products for various types of cancer. The company works closely with leading scientists and universities to develop and explore new products. One of the main divisions of BARD1 Life Sciences is the exploration of biomarker-based test procedures for early cancer detection. It develops innovative concepts to create fast, reliable, objective, and affordable diagnostic platforms. The products include tests for breast, cervical, prostate, and colon cancer. Another important area of BARD1 Life Sciences' business is the development of therapies for cancer patients. The company has developed a highly advanced drug discovery platform and collaborates closely with leading research institutions. The products range from immunotherapies to targeted therapies and chemotherapy. An important milestone in the history of BARD1 Life Sciences was the discovery of a new cancer gene called BARD1. The company found a new way to fight cancer through this discovery. The BARD1 gene is a tumor suppressor gene that malfunctions in many different types of cancer. The company has acquired exclusive rights to use this gene for diagnostic and therapeutic purposes. BARD1 Life Sciences has also formed partnerships with major pharmaceutical companies such as Bio-Rad Laboratories and Daiichi Sankyo to support product marketing and distribution. The company has also filed patents for several of its products to protect its innovations. The business model of BARD1 Life Sciences is based on the development of innovative products to improve cancer diagnosis and therapy. The different divisions include both diagnostics and therapeutics. The use of the BARD1 gene gives the company a unique competitive advantage and helps differentiate its products from those of competitors. Overall, BARD1 Life Sciences has established itself in the biotechnology industry and is working hard to develop new products that advance cancer research and improve patient care. With a strong pipeline of products and a growing number of partnerships, the company is well positioned to continue offering innovative solutions for cancer treatment.

BARD1 Life Sciences 배당금은 얼마입니까?

BARD1 Life Sciences은(는) 연간 번의 배당을 통해 0 AUD의 배당금을 지급합니다.

BARD1 Life Sciences이 얼마나 자주 배당을 지급하나요?

BARD1 Life Sciences의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

BARD1 Life Sciences ISIN이 무엇입니까?

BARD1 Life Sciences의 ISIN은 AU000000BD12입니다.

BARD1 Life Sciences WKN은 무엇인가요?

BARD1 Life Sciences의 WKN은 A2AL50입니다.

BARD1 Life Sciences 티커는 무엇인가요?

BARD1 Life Sciences의 티커는 BD1.AX입니다.

BARD1 Life Sciences이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 BARD1 Life Sciences은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 BARD1 Life Sciences은(는) 0 AUD의 배당금을 지급할 것으로 예상됩니다.

BARD1 Life Sciences의 배당 수익률은 얼마입니까?

BARD1 Life Sciences의 현재 배당 수익률은 입니다.

BARD1 Life Sciences의 배당금은 언제 지급되나요?

BARD1 Life Sciences은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

BARD1 Life Sciences의 배당금은 얼마나 안전한가요?

BARD1 Life Sciences은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

BARD1 Life Sciences의 배당금은 얼마입니까?

향후 12개월 동안 0 AUD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

BARD1 Life Sciences이(가) 속해 있는 섹터는 어디인가요?

BARD1 Life Sciences은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von BARD1 Life Sciences kaufen, um die vorherige Dividende zu erhalten?

BARD1 Life Sciences의 마지막 배당금을 0 AUD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

BARD1 Life Sciences의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

BARD1 Life Sciences의 2023년도 배당금은 얼마였습니까?

2023년에 BARD1 Life Sciences는 0 AUD를 배당금으로 지급했습니다.

BARD1 Life Sciences는 어떤 화폐로 배당금을 지급하나요?

BARD1 Life Sciences의 배당금은 AUD에 지급됩니다.

BARD1 Life Sciences 티커	BARD1 Life Sciences FIGI
EUG:EO	BBG000QB5ZX7
EUG:E1	BBG000QB6535
EUGEUR:EO	BBG00D3DBFW8
EUGEUR:XJ	BBG00D3DBG47
EUGEUR:XS	BBG00D3DBGC8
EUGEUR:E1	BBG00D3DBGF5
EUG:XX	BBG00JN77BK3
EUGEUR:XX	BBG00JN8HXN9
EUG:EP	BBG00RCXXPQ4
EUG:EZ	BBG00RCXXPS2

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커BD1.AX

ISINAU000000BD12

WKNA2AL50

BARD1 Life Sciences 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

BARD1 Life Sciences 주가 이력

BARD1 Life Sciences 주식 매출, EBIT, 이익 AU000000BD12 · A2AL50

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

BARD1 Life Sciences 매출, 이익 및 EBIT 역사

BARD1 Life Sciences 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

BARD1 Life Sciences 주식 마진 AU000000BD12 · A2AL50

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

BARD1 Life Sciences 마진 역사

BARD1 Life Sciences 주식 매출, EBIT, 주당 순이익 AU000000BD12 · A2AL50

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

BARD1 Life Sciences 매출, 이익 및 EBIT 주당 역사

BARD1 Life Sciences 주식 및 주식 분석

BARD1 Life Sciences Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

BARD1 Life Sciences 역사적인 P/E, EBIT 및 P/S에 따른 평가

BARD1 Life Sciences 주식 수량 AU000000BD12 · A2AL50

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

BARD1 Life Sciences 주식 분할

한눈에 과소평가된 주식을 인식하세요.

BARD1 Life Sciences 수익 예상

BARD1 Life Sciences 수익 놀라움

BARD1 Life Sciences 주식 주주 구조

BARD1 Life Sciences 주식에 대한 자주 묻는 질문